Funded Tech Companies
Dualitas Therapeutics
Headquartered in San Francisco, Dualitas Therapeutics has funding from Eli Lilly and Company, Alexandria Venture Investments and Qiming Venture Partners USA.
Company Overview
Company Name
Dualitas Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
San Francisco, CA Undisclosed
USA
San Francisco, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Dualitas Therapeutics, Inc. is a biotechnology company pioneering next-generation bispecific antibody (BsAb) therapies for immunology and inflammation (I&I). Dualitas' portfolio, built from its DualScreen discovery engine, includes lead programs DTX-103 in allergic disease and DTX-102 in autoimmune disease, with numerous other discoveries based on cell-surface proximity biology and novel co-target pairing.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/16/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rich Murray
Company Investors
- Eli Lilly and Company
- Alexandria Venture Investments
- Qiming Venture Partners USA
- SV Health Investors
- Versant Ventures (Alicia Levey)
Browse more funded tech companies:
Dual Aperture International | Duality
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs